Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AMGEN INC. Hits Price Target Forecast with 13.59% Profit Achieved

January 02, 2024
AMGEN INC. has successfully reached the price target forecast set by QuantWave on January 2, 2024. The forecast signal was initiated on August 15, 2023, with a predicted direction of long when the stock was priced at 249.89 $. The target price of 283.85 $ was reached, resulting in a profit of 13.59%. This achievement highlights the accuracy and effectiveness of QuantWave's analytics in identifying profitable opportunities in the market.

Market analysis indicates that several factors contributed to AMGEN INC.'s stock movement, such as positive earnings reports, advancements in their pipeline of innovative biotechnology products, and overall market sentiment towards the healthcare sector. By accurately forecasting the upward trend in AMGEN INC.'s stock price, QuantWave has demonstrated its ability to provide valuable insights for investors seeking to maximize their returns.

QuantWave is an automated forecasting platform that offers predictions for a wide range of stocks, presenting opportunities for potential profits. For those looking to enhance their understanding of QuantWave's investment strategy, QuantSchool provides comprehensive educational resources on how to generate consistent income using the forecasting system. By leveraging QuantWave's predictive analytics and QuantSchool's investment framework, investors can make informed decisions for sustainable financial growth.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


AMGNSeptember 20, 2023AMGEN INC. Hits Price Target Forecast with 16.3% Profit, QuantWave's Success in Analytics Showcased  ~1 min.

AMGEN INC. has successfully reached the price target forecast set by QuantWave with a profit of 16.3%. The forecast signal was issued on July 25, 2023, at a price of 221.05 $....


BIIBOctober 8, 2024Biogen Inc. Stock Hits Price Target Forecast with 9.14% Profit: A Success Story for QuantWave  ~2 min.

Biogen Inc., a leading biotechnology company, saw its stock price hit the forecasted target with a profit of 9.14% in a short position signaled by QuantWave on September 10, 2024, at a price of 200.64$....


BIIBApril 3, 2025Biogen Inc. Hits Price Target Forecast with 10.16% Profit - A Success Story for QuantWave  ~1 min.

Biogen Inc (BIIB) investors recently celebrated a successful price target forecast achievement, thanks to QuantWave's accurate prediction....


BIIBDecember 24, 2024Biogen Stock: Is BIIB Underperforming the Healthcare Sector?  ~2 min.

Biogen Inc. (NASDAQ: BIIB), a leading biotechnology company, has been facing scrutiny over its performance in the healthcare sector....


UNHJuly 16, 2024UNITEDHEALTH GROUP INCORPORATED Hits Price Target Forecast on QuantWave, Generating 10.16% Profit  ~1 min.

UNITEDHEALTH GROUP INCORPORATED has successfully reached the price target forecast set by QuantWave, leading to a profit of 10.16%. The forecast signal date was 2024-07-02, with a price of 492....